Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial
Youyi Fong, Adrian B. McDermott, David Benkeser, Sanne Roels, Daniel J. Stieh, An Vandebosch, Mathieu Le Gars, Griet A. Van Roey, Christopher R. Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Obrimpong Amoa-Awua, Manjula Basappa, Britta Flach, Bob C. Lin, Christopher Moore, Mursal Naisan, Muhammed Naqvi, Sandeep Narpala, Sarah O’Connell, Allen Mueller, Leo Serebryannyy, Mike Castro, Jennifer Wang, Christos J. Petropoulos, Alex Luedtke, Ollivier Hyrien, Yiwen Lu, Chenchen Yu, Bhavesh Borate, Lars W. P. van der Laan, Nima S. Hejazi, Avi Kenny, Marco Carone, Daniel N. Wolfe, Jerald Sadoff, Glenda E. Gray, Beatriz Grinsztejn, Paul A. Goepfert, Susan J. Little, Leonardo Paiva de Sousa, Rebone Maboa, April K. Randhawa, Michele P. Andrasik, Jenny Hendriks, Carla Truyers, Frank Struyf, Hanneke Schuitemaker, Macaya Douoguih, James G. Kublin, Lawrence Corey, Kathleen M. Neuzil, View ORCID ProfileLindsay N. Carpp, Dean Follmann, Peter B. Gilbert, Richard A. Koup, Ruben O. Donis, the Janssen Team, the Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team, the United States Government (USG)/CoVPN Biostatistics Team the Immune Assays Team
doi: https://doi.org/10.1101/2022.04.06.22272763
Youyi Fong
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
2Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
Adrian B. McDermott
3Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
David Benkeser
4Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA
Sanne Roels
5Janssen R&D, a division of Janssen Pharmaceutica NV, Beerse, Belgium
Daniel J. Stieh
6Janssen Vaccines and Prevention, Leiden, the Netherlands
An Vandebosch
5Janssen R&D, a division of Janssen Pharmaceutica NV, Beerse, Belgium
Mathieu Le Gars
6Janssen Vaccines and Prevention, Leiden, the Netherlands
Griet A. Van Roey
6Janssen Vaccines and Prevention, Leiden, the Netherlands
Christopher R. Houchens
7Biomedical Advanced Research and Development Authority, Washington, DC, USA
Karen Martins
7Biomedical Advanced Research and Development Authority, Washington, DC, USA
Lakshmi Jayashankar
7Biomedical Advanced Research and Development Authority, Washington, DC, USA
Flora Castellino
7Biomedical Advanced Research and Development Authority, Washington, DC, USA
Obrimpong Amoa-Awua
3Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Manjula Basappa
3Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Britta Flach
3Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Bob C. Lin
3Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Christopher Moore
3Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Mursal Naisan
3Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Muhammed Naqvi
3Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Sandeep Narpala
3Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Sarah O’Connell
3Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Allen Mueller
3Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Leo Serebryannyy
3Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Mike Castro
3Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Jennifer Wang
3Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Christos J. Petropoulos
8LabCorp-Monogram Biosciences, South San Francisco, CA, USA
Alex Luedtke
9Department of Statistics, University of Washington, Seattle, WA, USA
Ollivier Hyrien
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
2Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
Yiwen Lu
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
Chenchen Yu
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
Bhavesh Borate
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
Lars W. P. van der Laan
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
9Department of Statistics, University of Washington, Seattle, WA, USA
Nima S. Hejazi
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
10Division of Biostatistics, School of Public Health, Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA
Avi Kenny
11Department of Biostatistics, University of Washington School of Public Health, Seattle, WA, USA
Marco Carone
11Department of Biostatistics, University of Washington School of Public Health, Seattle, WA, USA
Daniel N. Wolfe
7Biomedical Advanced Research and Development Authority, Washington, DC, USA
Jerald Sadoff
6Janssen Vaccines and Prevention, Leiden, the Netherlands
Glenda E. Gray
12Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
13South African Medical Research Council, Cape Town, South Africa
Beatriz Grinsztejn
14Evandro Chagas National Institute of Infectious Diseases-Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil
Paul A. Goepfert
15Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
Susan J. Little
16Division of Infectious Diseases, University of California San Diego, La Jolla, CA, USA
Leonardo Paiva de Sousa
14Evandro Chagas National Institute of Infectious Diseases-Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil
Rebone Maboa
17Ndlovu Elandsdoorn Site, Limpopo, Dennilton, South Africa
April K. Randhawa
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
Michele P. Andrasik
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
Jenny Hendriks
6Janssen Vaccines and Prevention, Leiden, the Netherlands
Carla Truyers
5Janssen R&D, a division of Janssen Pharmaceutica NV, Beerse, Belgium
Frank Struyf
5Janssen R&D, a division of Janssen Pharmaceutica NV, Beerse, Belgium
Hanneke Schuitemaker
6Janssen Vaccines and Prevention, Leiden, the Netherlands
Macaya Douoguih
6Janssen Vaccines and Prevention, Leiden, the Netherlands
James G. Kublin
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
Lawrence Corey
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
18Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA
Kathleen M. Neuzil
19Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA
Lindsay N. Carpp
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
Dean Follmann
20Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Peter B. Gilbert
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
2Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
11Department of Biostatistics, University of Washington School of Public Health, Seattle, WA, USA
Richard A. Koup
3Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Ruben O. Donis
7Biomedical Advanced Research and Development Authority, Washington, DC, USA
Data Availability
The complete de-identified patient data set will be made available to others. The data sharing policy of Janssen Pharmaceutical Companies of Johnson & Johnson is available at https://www.janssen.com/clinical-trials/ transparency. As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at http://yoda.yale.edu.
Posted April 12, 2022.
Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial
Youyi Fong, Adrian B. McDermott, David Benkeser, Sanne Roels, Daniel J. Stieh, An Vandebosch, Mathieu Le Gars, Griet A. Van Roey, Christopher R. Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Obrimpong Amoa-Awua, Manjula Basappa, Britta Flach, Bob C. Lin, Christopher Moore, Mursal Naisan, Muhammed Naqvi, Sandeep Narpala, Sarah O’Connell, Allen Mueller, Leo Serebryannyy, Mike Castro, Jennifer Wang, Christos J. Petropoulos, Alex Luedtke, Ollivier Hyrien, Yiwen Lu, Chenchen Yu, Bhavesh Borate, Lars W. P. van der Laan, Nima S. Hejazi, Avi Kenny, Marco Carone, Daniel N. Wolfe, Jerald Sadoff, Glenda E. Gray, Beatriz Grinsztejn, Paul A. Goepfert, Susan J. Little, Leonardo Paiva de Sousa, Rebone Maboa, April K. Randhawa, Michele P. Andrasik, Jenny Hendriks, Carla Truyers, Frank Struyf, Hanneke Schuitemaker, Macaya Douoguih, James G. Kublin, Lawrence Corey, Kathleen M. Neuzil, Lindsay N. Carpp, Dean Follmann, Peter B. Gilbert, Richard A. Koup, Ruben O. Donis, the Janssen Team, the Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team, the United States Government (USG)/CoVPN Biostatistics Team
medRxiv 2022.04.06.22272763; doi: https://doi.org/10.1101/2022.04.06.22272763
Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial
Youyi Fong, Adrian B. McDermott, David Benkeser, Sanne Roels, Daniel J. Stieh, An Vandebosch, Mathieu Le Gars, Griet A. Van Roey, Christopher R. Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Obrimpong Amoa-Awua, Manjula Basappa, Britta Flach, Bob C. Lin, Christopher Moore, Mursal Naisan, Muhammed Naqvi, Sandeep Narpala, Sarah O’Connell, Allen Mueller, Leo Serebryannyy, Mike Castro, Jennifer Wang, Christos J. Petropoulos, Alex Luedtke, Ollivier Hyrien, Yiwen Lu, Chenchen Yu, Bhavesh Borate, Lars W. P. van der Laan, Nima S. Hejazi, Avi Kenny, Marco Carone, Daniel N. Wolfe, Jerald Sadoff, Glenda E. Gray, Beatriz Grinsztejn, Paul A. Goepfert, Susan J. Little, Leonardo Paiva de Sousa, Rebone Maboa, April K. Randhawa, Michele P. Andrasik, Jenny Hendriks, Carla Truyers, Frank Struyf, Hanneke Schuitemaker, Macaya Douoguih, James G. Kublin, Lawrence Corey, Kathleen M. Neuzil, Lindsay N. Carpp, Dean Follmann, Peter B. Gilbert, Richard A. Koup, Ruben O. Donis, the Janssen Team, the Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team, the United States Government (USG)/CoVPN Biostatistics Team
medRxiv 2022.04.06.22272763; doi: https://doi.org/10.1101/2022.04.06.22272763
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (678)
- Anesthesia (182)
- Cardiovascular Medicine (2678)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12310)
- Forensic Medicine (10)
- Gastroenterology (769)
- Genetic and Genomic Medicine (4156)
- Geriatric Medicine (390)
- Health Economics (685)
- Health Informatics (2693)
- Health Policy (1010)
- Hematology (365)
- HIV/AIDS (861)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (444)
- Neurology (3931)
- Nursing (212)
- Nutrition (584)
- Oncology (2071)
- Ophthalmology (595)
- Orthopedics (243)
- Otolaryngology (307)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1131)
- Primary Care Research (461)
- Public and Global Health (6577)
- Radiology and Imaging (1420)
- Respiratory Medicine (876)
- Rheumatology (414)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (54)
- Transplantation (189)
- Urology (169)